// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Audit on the management of dyslipidaemia in patients presenting with acute myocardial infarction as per esc guidance in a district general hospital are we meeting targets

Alice Wong - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

Ezetimibe

Prevalence of a nice defined indication for inclisiran in a real world trans pandemic acute coronary syndrome cohort

Nimisha Shaji - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

N/A

Changing cardiac care a 24 7 cardiac service for emergency care in the post pandemic era

Mohamed Magdy Abdelrazik Edries - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Angina

N/A

Mindfulness based intervention in patients with persistent pain in chest mipic of non cardiac cause a feasibility randomised control study

Tarun Mittal - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Transoesophageal atrial pacing stress echocardiography as a viable alternative to exercise and pharmacological stress echocardiography

Maria Stefil - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Impulse cvd improving outcomes for people at risk of with cardiovascular disease in the west midlands

Simon Duckett - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Hypercholesterolemia, Familial, 1

N/A

Long noncoding RNA STX18 AS1 regulates in vitro cardiomyocyte differentiation

Yingjuan Liu - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Joint analysis of functionally related genes yields further candidates associated with tetralogy of fallot

Alexandru Chelu - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Tetralogy of fallot

N/A

High resolution single cell analysis of the developing human heart

Semih Bayraktar - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Enhancing cardiac regeneration the role of fibronectin in stem cell derived epicardial cardiomyocyte crosstalk

Jonathan Chuo Min Lee - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Tetracycline

Characterising spatiotemporal membrane and F actin dynamics in Kugeln a novel endothelial membrane behaviour in the zebrafish cerebral vasculature

Dhruv Shah - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Pro angiogenic injectable self assembling peptide hydrogel as a delivery vehicle for cardiac cell therapies

Katharine King - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Combined role for yap tead and YAP RUNX2 signalling in substrate stiffness regulation of cardiac fibroblast proliferation

Mark Bond - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Adipose tissue derived ceramides regulate myocardial redox state and predict cardiovascular outcomes

Murray Polkinghorne - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Nitric oxide

Microtubule associated protein 1S MAP1S enhances cardiomyocyte viability by promoting autophagy and inhibiting apoptosis

Pia Camila Morales Araya - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

chloroquine

Novel T type calcium current pharmacology shows promise in the study of atrial fibrillation

Aled Jones - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

ST101

Calmodulin mutations associated with long QT syndrome impair L type calcium channel regulation

Nitika Gupta - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Long QT syndrome

Betahistine Hydrochloride

Genome wide association study coupled with promoter interactomic data identifies neuroplastin NPTN as a potential novel gene regulating heart rate

Mun-Kit Choy - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

First demonstration of a novel experimental model of atherosclerosis The ex vivo on ecmo amputated living human limb model

Adam Hartley - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

In vivo whole body fluorescence molecular imaging of experimental atherosclerosis using anti malondialdehyde modified low density lipoprotein humanised antibody fragment targeted nanoparticles

Adam Hartley - British Cardiovascular Society (BCS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

N/A

Copyright © 2026. QuantiNova All rights reserved